Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening | PLOS ONE
![Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations | Semantic Scholar Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/46a04ee9790c841bb1f691cde63f75a89c358e2d/3-Table1-1.png)
Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations | Semantic Scholar
![Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open](https://cyberleninka.org/viewer_images/1260895/f/1.png)
Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open
![Molecular mechanisms underpinning sarcomas and implications for current and future therapy | Signal Transduction and Targeted Therapy Molecular mechanisms underpinning sarcomas and implications for current and future therapy | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-021-00647-8/MediaObjects/41392_2021_647_Fig1_HTML.png)
Molecular mechanisms underpinning sarcomas and implications for current and future therapy | Signal Transduction and Targeted Therapy
![Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a0df47c1-4246-451c-beb9-a2a01704e743/gr1_lrg.jpg)
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov | BMC Cancer | Full Text The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-5163-2/MediaObjects/12885_2018_5163_Fig2_HTML.png)
The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov | BMC Cancer | Full Text
![Cancers | Free Full-Text | Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results Cancers | Free Full-Text | Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results](https://www.mdpi.com/cancers/cancers-05-00529/article_deploy/html/images/cancers-05-00529-g001.png)
Cancers | Free Full-Text | Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results
![Current treatment landscape and emerging management options for extremity sarcoma Turkar S - Cancer Res Stat Treat Current treatment landscape and emerging management options for extremity sarcoma Turkar S - Cancer Res Stat Treat](https://www.crstonline.com/articles/2018/1/2/images/CancerResStatTreat_2018_1_2_121_258547_f1.jpg)
Current treatment landscape and emerging management options for extremity sarcoma Turkar S - Cancer Res Stat Treat
![Patrick Schöffski on Twitter: "I now have two MDM2 inhibitors available in ongoing clinical trials in Leuven for patients with advanced dedifferentiated liposarcoma and select other mesenchymal and epithelial tumours with MDM2 Patrick Schöffski on Twitter: "I now have two MDM2 inhibitors available in ongoing clinical trials in Leuven for patients with advanced dedifferentiated liposarcoma and select other mesenchymal and epithelial tumours with MDM2](https://pbs.twimg.com/media/FHOZCqtXoAcTthH.jpg:large)
Patrick Schöffski on Twitter: "I now have two MDM2 inhibitors available in ongoing clinical trials in Leuven for patients with advanced dedifferentiated liposarcoma and select other mesenchymal and epithelial tumours with MDM2
![Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma - Annals of Oncology Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/10071cf9-ff61-45d1-ad6a-963a4f288032/gr1.jpg)
Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma - Annals of Oncology
![Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard | Scientific Reports Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-12132-w/MediaObjects/41598_2017_12132_Fig1_HTML.jpg)
Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard | Scientific Reports
![Cureus | Hyperprogression of Liver Metastasis With Neoadjuvant Immunotherapy for Soft Tissue Sarcoma Cureus | Hyperprogression of Liver Metastasis With Neoadjuvant Immunotherapy for Soft Tissue Sarcoma](https://assets.cureus.com/uploads/figure/file/121087/lightbox_e175c020a14411eab8dc67254061205a-Figure-tiff.png)